MBD2 and lung carcinoma: Since lung cancers ((non-small cell lung cancers (NSCLCs) in particular) are one of the highest-ranking causes of cancer-related death worldwide and LUAD is the most prevalent subtype of NSCLCs [23], we thus first examined MBD2 expression in the lung samples obtained from 69 LUAD patients.